Results 41 to 50 of about 1,369,314 (252)

Structural Dependence of Sulfated Polysaccharide for Diabetes Management: Fucoidan From Undaria pinnatifida Inhibiting α-Glucosidase More Strongly Than α-Amylase and Amyloglucosidase

open access: yesFrontiers in Pharmacology, 2020
Fucoidan refers to a group of sulfated polysaccharide that is commonly obtained from various species of brown seaweed. Fucoidan has gained increased popularity among researchers in the recent years due to its numerous biological activities, including its
Hui Si Audrey Koh   +8 more
doaj   +1 more source

Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores

open access: yesMicroorganisms, 2023
This study examines the possibility of directly producing and utilizing useful substances in the intestines of animals using anaerobic bacteria that can grow in the intestines of animals.
Hee-Woong Kim   +3 more
doaj   +1 more source

α-Glucosidase and α-Amylase Inhibitory Compounds from three African Medicinal Plants: An Enzyme Inhibition Kinetics Approach

open access: yesNatural Product Communications, 2017
The quest to find new lead compounds with anti-diabetic effects via the inhibition of α-glucosidase and α-amylase had led us to conduct bioassay guided isolation of three African medicinal plants which resulted in the identification of bicyclo[2.2.0 ...
Mohammed Auwal Ibrahim   +3 more
doaj   +1 more source

Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole-N-phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors† [PDF]

open access: yesRSC Advances
A series of thirteen new 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole-N-phenylacetamide) derivatives 8a–m were synthesized as potent α-glucosidase inhibitors.
Shohreh Bakhshi Varzaneh   +8 more
doaj   +1 more source

Effects of Acarbose, an α-Glucosidase Inhibitor (BAY G 5421), on Orally Loaded Glucose, Maltose and Sucrose and on Blood Glucose Control in Non-Insulin-Dependent Diabetics [PDF]

open access: yes, 1985
1985-01Fifty g glucose, 50g maltose and 50g sucrose were loaded to 12 nonobese healthy male volunteers with and without 100 or 300 mg α-glucosidase inhibitor, acarbose, and the inhibitory effect on digestion and absorption of these saccharides was ...
NODA, AIJI   +3 more
core   +1 more source

Carnitine is a pharmacological allosteric chaperone of the human lysosomal α-glucosidase

open access: yes, 2022
Pompe disease is an inherited metabolic disorder due to the deficiency of the lysosomal acid α-glucosidase (GAA). The only approved treatment is enzyme replacement therapy with the recombinant enzyme (rhGAA).
Roberta Iacono (4610482)   +12 more
core   +1 more source

Isolation of a Novel Anti-Diabetic α-Glucosidase Oligo-Peptide Inhibitor from Fermented Rice Bran

open access: yes, 2023
At present, the incidence rate of diabetes is increasing gradually, and inhibiting α-glucosidase is one of the effective methods used to control blood sugar.
Jingfei Hu   +7 more
core   +1 more source

Successfully Treated Pneumatosis Cystoides Intestinalis with Pneumoperitoneum Onset in a Patient Administered α-glucosidase Inhibitor [PDF]

open access: yes, 2013
An 80-year-old woman, who had been administered α-glucosidase inhibitor for diabetes, was brought to the hospital with the sensation of abdominal fullness and pain.
Tanabe, Shunsuke   +8 more
core   +1 more source

Comparison of Efficacies of a Dipeptidyl Peptidase IV Inhibitor and α-Glucosidase Inhibitors in Oral Carbohydrate and Meal Tolerance Tests and the Effects of Their Combination in Mice

open access: yesJournal of Pharmacological Sciences, 2007
E3024 (3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate) is a dipeptidyl peptidase IV (DPP-IV) inhibitor. Since the target of both DPP-IV inhibitors and α-glucosidase inhibitors is the lowering of postprandial ...
Kazuto Yamazaki   +8 more
doaj   +1 more source

Intestinal α-Glucosidase Inhibitors in Achillea millefolium [PDF]

open access: yes, 2017
Achillea millefolium is a plant used as a component of anti-diabetic preparation but the bioactive compounds responsible for its use are not known. Inhibition of intestinal α-glucosidase is a preferable effect for prevention and treatment of diabetes ...
Kato, Eisuke, Noda, Kota, Kawabata, Jun
core   +1 more source

Home - About - Disclaimer - Privacy